Switch to: References

Add citations

You must login to add citations.
  1. Shackling the shoulders of giants: A report on excerpts from the national Academies’ symposium on the role of scientific and technical data and information in the public domain, Washington, DC, sEptember 5–6, 2002.John S. Gardenier - 2003 - Science and Engineering Ethics 9 (3):425-434.
    This paper informally summarizes a two-day symposium held at the U.S. National Academy of Sciences in Washington, D.C., September 5–6, 2002. The issue was to what extent the progress of science and societal capacity for continued technological innovation are threatened by excessive protection of intellectual property. Excessive protection creates disadvantages not only for scientists and inventors but also for educators/students and for librarians/clientele. Speakers from a variety of disciplines and institutions agreed unanimously that scientific and technological progress is, indeed, under (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethico-legal issues in biomedicine patenting: A patent professional viewpoint.R. Stephen Crespi - 2005 - Science and Engineering Ethics 11 (1):117-136.
    Over the last two decades, the ethical implications of patents for biological materials and processes have been the subject of spirited public debate between the many individuals and groups on which the patent system impacts. Whereas copyright, trade marks, and other species of Intellectual Property Rights (IPR) are widely acceptable, the patent system evokes criticism from many quarters, especially in relation to the legal protection of inventions in the Life Sciences. Some of these criticisms expressed by prestigious public organisations are (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • The Commercialization of Human Stem Cells: Ethical and Policy Issues. [REVIEW]David B. Resnik - 2002 - Health Care Analysis 10 (2):127-154.
    The first stage of the human embryonic stem(ES) cell research debate revolved aroundfundamental questions, such as whether theresearch should be done at all, what types ofresearch may be done, who should do theresearch, and how the research should befunded. Now that some of these questions arebeing answered, we are beginning to see thenext stage of the debate: the battle forproperty rights relating to human ES cells. The reason why property rights will be a keyissue in this debate is simple and (...)
    Download  
     
    Export citation  
     
    Bookmark   17 citations  
  • (1 other version)DNA Patents and Human Dignity.David B. Resnik - 2001 - Journal of Law, Medicine and Ethics 29 (2):152-165.
    Those objecting to human DNA patenting frequently do so on the grounds that the practice violates or threatens human dignity. For example, from 1993 to 1994, more than thirty organizations representing indigenous peoples approved formal declarations objecting to the National Institutes of Health's bid to patent viral DNA taken from subjects in Papua New Guinea and the Solomon Islands. Although these were not patents on human DNA, the organizations argued that the patents could harm and exploit indigenous peoples and violate (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations  
  • Bioterrorism and patent rights: "Compulsory licensure" and the case of cipro.David B. Resnik & Kenneth A. De Ville - 2002 - American Journal of Bioethics 2 (3):29 – 39.
    Download  
     
    Export citation  
     
    Bookmark   11 citations  
  • Ethical reasons for narrowing the scope of biotech patents.Tom Andreassen - 2015 - Medicine, Health Care and Philosophy 18 (4):463-473.
    Patents on biotech products have a scope that goes well beyond what is covered by the most widely applied ethical justifications of intellectual property. Neither natural rights theory from Locke, nor public interest theory of IP rights justifies the wide scope of legal protection. The article takes human genes as an example, focusing on the component that is not invented but persists as unaltered gene information even in the synthetically produced complementary DNA, the cDNA. It is argued that patent on (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Genes in court.Raymond Spier - 2001 - Science and Engineering Ethics 7 (1):3-6.
    Download  
     
    Export citation  
     
    Bookmark   4 citations